Ryan Willman - Calumet Specialty LLC GP
| CLMT Stock | USD 21.38 0.45 2.06% |
Insider
Ryan Willman is LLC GP of Calumet Specialty Products
| Age | 46 |
| Address | 1060 N Capitol Ave, Indianapolis, IN, United States, 46204-1044 |
| Phone | 317-328-5660 |
| Web | https://calumet.com |
Ryan Willman Latest Insider Activity
Tracking and analyzing the buying and selling activities of Ryan Willman against Calumet Specialty stock is an integral part of due diligence when investing in Calumet Specialty. Ryan Willman insider activity provides valuable insight into whether Calumet Specialty is net buyers or sellers over its current business cycle. Note, Calumet Specialty insiders must abide by specific rules, including filing SEC forms every time they buy or sell Calumet Specialty'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Ryan Willman over a year ago Exercise or conversion by Ryan Willman of 7500 shares of Calumet Specialty subject to Rule 16b-3 | ||
Ryan Willman over a year ago Acquisition by Ryan Willman of 5030 shares of Calumet Specialty subject to Rule 16b-3 | ||
Ryan Willman over a year ago Acquisition by Ryan Willman of 9226 shares of Calumet Specialty subject to Rule 16b-3 | ||
Ryan Willman over a year ago Acquisition by Ryan Willman of 9809 shares of Calumet Specialty subject to Rule 16b-3 |
Calumet Specialty Management Efficiency
The company has return on total asset (ROA) of 0.0167 % which means that it generated a profit of $0.0167 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.7222) %, meaning that it created substantial loss on money invested by shareholders. Calumet Specialty's management efficiency ratios could be used to measure how well Calumet Specialty manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Calumet Specialty's Return On Tangible Assets are comparatively stable compared to the past year. Return On Capital Employed is likely to gain to 0.17 in 2024, despite the fact that Return On Equity is likely to grow to (0.09). At this time, Calumet Specialty's Total Current Liabilities is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 79.1 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 1.8 B in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Marcela Vaca | GeoPark | 56 | |
| Marinos Baghdati | Ring Energy | 47 | |
| J Clarkson | CNX Resources Corp | 64 | |
| Angela Busch | Magnolia Oil Gas | 54 | |
| JohnDavis Rutkauskas | Battalion Oil Corp | N/A | |
| Thomas Mitchell | Ring Energy | 57 | |
| Robert Moses | Gulfport Energy Operating | 44 | |
| Andrs Ocampo | GeoPark | 46 | |
| Davis OConnor | Permian Resources | 69 | |
| Tyler Farquharson | Granite Ridge Resources | 42 | |
| Matthew CFA | Granite Ridge Resources | 40 | |
| James Larson | Magnolia Oil Gas | 71 | |
| David Reganato | Gulfport Energy Operating | N/A | |
| Jason Martinez | Gulfport Energy Operating | N/A | |
| Glen Brown | PHX Minerals | 64 | |
| Alan Shepard | CNX Resources Corp | 43 | |
| Martin Terrado | GeoPark | 49 | |
| Steven Packebush | PHX Minerals | 55 | |
| Ravi Srivastava | CNX Resources Corp | 42 | |
| Hollie Lamb | Ring Energy | 48 | |
| Benjamin Conner | Crescent Energy Co | 38 | |
Management Performance
| Return On Equity | -11.72 | ||||
| Return On Asset | 0.0167 |
Calumet Specialty Leadership Team
Elected by the shareholders, the Calumet Specialty's board of directors comprises two types of representatives: Calumet Specialty inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Calumet. The board's role is to monitor Calumet Specialty's management team and ensure that shareholders' interests are well served. Calumet Specialty's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Calumet Specialty's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chris Hodges, Alpha IR | ||
| Louis Borgmann, CEO President | ||
| Marc Lawn, LLC GP | ||
| Vincent Donargo, Chief Officer | ||
| Brad McMurray, Director Relations | ||
| David Lunin, Executive CFO | ||
| Stephen Mawer, Independent Director of Calumet GP, LLC | ||
| Scott Obermeier, LLC GP | ||
| Gregory Morical, General VP | ||
| John Kompa, Director Relations | ||
| Bruce Fleming, Executive Vice President - Strategy and Growth of Calumet GP, LLC | ||
| Ryan Willman, LLC GP |
Calumet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Calumet Specialty a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -11.72 | ||||
| Return On Asset | 0.0167 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 3.94 B | ||||
| Shares Outstanding | 85.9 M | ||||
| Shares Owned By Insiders | 21.24 % | ||||
| Shares Owned By Institutions | 37.43 % | ||||
| Number Of Shares Shorted | 5.37 M | ||||
| Price To Earning | 286.67 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.